Visual symptoms in a patient treated with MEK inhibitors.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of ophthalmology"
DOI: 10.1177/11206721221145739
Abstract: PURPOSE to report an uncommon presentation of Encorafenib-Binimetinib retinal side effects. CASE REPORT A 56-year-old Caucasian woman, naïve to previous chemotherapies, was started on Encorafenib/Binimetinib for metastatic melanoma. After seven hours from the first 45 mg… read more here.
Keywords: patient treated; visual symptoms; symptoms patient; patient ... See more keywords